Damage to the Heart after Radiotherapy in Childhood
Authors:
K. Hudecová; B. Mladosievičová
Authors‘ workplace:
Ústav patologickej fyziológie, Lekárska fakulta Univerzity Komenského, Bratislava
prednosta doc. MUDr. M. Bernadič, CSc., mim. prof.
Published in:
Čes-slov Pediat 2008; 63 (4): 194-200.
Category:
Review
Overview
The treatment of the child suffering from cancer carries a lot of risk into the future. Radiotherapy involving the chest, cranial and abdominal area can lead to late cardiovascular complications. Mediastinal radiotherapy may induce the damage of pericardium, myocardium, or coronary vasculature and causes the endothelial dysfunction and fibrosis. Radiotherapy can significantly contribute to the development of pericardial effusion, constrictive pericarditis, ischemic heart disease, myocardial infarction, valvular disorders, arrhythmias and other complications. Mutual connection between individual organ systems results in late effects which encourage and influence each other. The metabolic syndrome as a risk factor of atherogenesis and cardiovascular diseases is currently often discussed as a late effect of anti-cancer treatment, especially of cranial radiotherapy.
The identification of pathophysiological mechanisms of radiation-induced damage as well as using of new diagnostic cardiologic methods in clinical practice would enable us to detect the late effects already at subclinical level. It is expected to prevent the risk of cardiovascular diseases even in patients without any symptoms by using appropriate prevention and therapeutic methods (ACE-inhibitors, anticoagulants, prophylactic measures of bacterial endocarditis).
Key words:
radiotherapy, Hodgkin’s disease, metabolic syndrome, cardiotoxicity, prevention
Sources
1. Birkholz D, Korpal-Szczyrska M, Kaminska H, et al. Influence of surgery and radiotherapy on growth and pubertal development in children treated for brain tumour. Med. Wieku Rozwoj 2005;9(3 Pt 2): 463–469.
2. Couto-Silva AC, Brauner R, Adan LF. Endocrine sequelae after radiotherapy in childhood and adolescence. Arq. Bras. Endocrinol. Metanol. 2005;49(5): 825–832.
3. Kourti M, Tragiannidis A, Makedou A, et al. Metabolic syndrome in children and adolescent with acute lymphoblastic leukemia after the completion of chemotherapy. J. Pediatr. Hematom. Oncol. 2005;27(9): 499–501.
4. Klimeš I. Účinok inzulínu, inzulínová rezistencia a syndróm inzulínovej rezistencie. In Hulín I, et al. Patofyziológia. 6.vyd. Bratislava: SAP, 2002: 1119–1135.
5. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006;107(6): 1303–1312.
6. Tahrani AA, Cramp C, Moulik P. The development of non-insulin-dependent diabetes after total body irradiation and bone marrow transplantation in adolescence: a case report and literature review. Pediatr. Diabetes 2006;7(3): 173–175.
7. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2003;21(7): 1359–1365.
8. Ross JA, Oeffinger KC, Davies SM, et al. Genetic variation in the leptin receptor and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2004;22(17): 3558–3562.
9. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97(3): 663–673.
10. Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin. Oncol. 2005;17(3): 153–159.
11. Adams MJ, Lipshultz SE. Pathophysiology of antracycline- and radiation-associated cardiomyophaties: Implications for sreening and prevention. Pediatr. Blood Cancer 2005;44: 600–606.
12. Guldner L, Haddy N, Pein F, et al. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer. Radiother. Oncol. 2006;81(1): 47–56.
13. Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin´s lymphoma. J. Clin. Oncol. 2007;25(1): 3–5.
14. Girinsky T, van der Maazen R, Specht L, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother. Oncol. 2006;79(3): 270–277.
15. Koontz BF, Kirkpatrick JP, Clough RW, et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin’s disease: Cure balanced against complications. J. Clin. Oncol. 2006;24(4): 605–611.
16. Diehl V, Brillant C, Engert A, et al. Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma: Interim analysis of a randomized trial of the German Hodgkin’s Study Group (GHSG). J. Clin. Oncol. 2005;23: 56.
17. Charniot JC, Zerhouni K, Kidouche R, et al. Late cardiac complications of radiation therapy. Presse Med. 2006;35(2 Pt 1): 239–242.
18. Ichinose T, Nakazato Y, Miyano H, et al. Severe infundibular pulmonary stenosis and coronary artery stenosis with ventricular tachycardia 24 years after mediastinal irradiation. Intern. Med. 2005;44(9): 963–966.
19. Aleman BMP, van den Belt-Duseboud AW, De Bruin ML, et al. Late cardiac toxicity after treatment for Hodgkin´s lymphoma. Blood 2006;109: 1878–1886.
20. Hull MC, Morris CG, Pepine CJ, et al. Valvular dysfunction and carodit, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003;290: 2831–2837.
21. Heindreich PA, Schnittger I, Strauss HW, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin´s disease. J. Clin. Oncol. 2007;25(1): 43–49.
22. Elbl L, Hrstkova H, Chaloupka V, et al. Dynamic stress echocardiography in asymptomatic patients treated for malignant diseases in childhood. Vnitř. Lék. 2003;49(4): 273–279.
23. Apter S, Shemesh J, Raanani P, et al. Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation. Coron. Artery Dis. 2006;17(2): 145–151.
24. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms´tumor. Int. J. Radiat. Oncol. Biol. Phys. 2000;46(5): 1239–1246.
25. Mladosievičová B, Kaiserová E, Foltínová A (Eds). Možné neskoré následky protinádorovej liečby v detstve. Bratislava: SAP, 2007. 212 s.
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2008 Issue 4
Most read in this issue
- Pertussis and GER – Two Causes of Long-term Cough
- Morphological View on Human Thymus Ontogenesis
- Factors Affecting Child Thymus Size and Involution
- Adverse Reactions Following Administration of BCG Vaccine in the Czech Republic in the Period 2001–2006